NCT03280927View on ClinicalTrials.gov

Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

November 10, 2017

Primary Completion Date

January 22, 2020

Study Completion Date

January 22, 2020

Conditions
Mild to Moderate Onychomycosis Due to Dermatophyte
Interventions
DRUG

Jublia®

Jublia® topical solution

Trial Locations (1)

Unknown

Konkuk University Medical Center, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT03280927 - Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis | Biotech Hunter | Biotech Hunter